This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Cardiovascular
Levemir® receives positive CHMP opinion for extended use in children as young as one year old
Read more
Poor sleep associated with increased risk of heart attack and stroke
Read more
Ozurdex® significantly improves vision in real-life study
Read more
Biological aortic heart valve calcification
Read more
Renin and aldosterone levels in hypertension
Read more
Aortic valve stenosis: treatment options
Read more
Treating coronary chronic total occlusions
Read more
New developments in PAD angioplasty
Read more
Developments in the treatment of heart failure
Read more
Recent developments in DCB angioplasty
Read more
Ablation technologies for cardiac arrhythmias
Read more
Nanomedicines: tomorrow’s challenge
Read more
Investigational heart failure medicine LCZ696 receives PIM designation in the UK
Read more
CHMP recommends empagliflozin/metformin HCl for approval in the EU
Read more
Brain activity during cardiac arrest
Read more
Zilver® PTX® thumbwheel stent delivery system receives CE Mark
Read more
Allpresan® diabetic foam creams launch in the UK
Read more
Page 29 of 39
« First
«
...
10
20
...
27
28
29
30
31
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: